These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 36790675)

  • 1. Progress of gut microbiome and its metabolomics in early screening of colorectal cancer.
    Zhou L; Jiang Z; Zhang Z; Xing J; Wang D; Tang D
    Clin Transl Oncol; 2023 Jul; 25(7):1949-1962. PubMed ID: 36790675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
    Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
    Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
    [No Abstract]   [Full Text] [Related]  

  • 3. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
    Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
    mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer and gut microbiota studies in China.
    Wang Z; Dan W; Zhang N; Fang J; Yang Y
    Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
    Avuthu N; Guda C
    Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
    Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
    Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiome: New biomarkers in early screening of colorectal cancer.
    Zhou P; Yang D; Sun D; Zhou Y
    J Clin Lab Anal; 2022 May; 36(5):e24359. PubMed ID: 35312122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of microbiome-derived biomarkers for early colorectal cancer detection.
    Zwezerijnen-Jiwa FH; Sivov H; Paizs P; Zafeiropoulou K; Kinross J
    Neoplasia; 2023 Feb; 36():100868. PubMed ID: 36566591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications.
    Wong SH; Yu J
    Nat Rev Gastroenterol Hepatol; 2019 Nov; 16(11):690-704. PubMed ID: 31554963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy.
    Russo E; Gloria LD; Nannini G; Meoni G; Niccolai E; Ringressi MN; Baldi S; Fani R; Tenori L; Taddei A; Ramazzotti M; Amedei A
    Neoplasia; 2023 Jun; 40():100901. PubMed ID: 37058886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of the gut microbiome, metabolites, and multi-omics biomarkers across the colorectal cancer care continuum.
    Wu Y; Shen N; Hope C; Noh HI; Richardson BN; Swartz MC; Bai J
    Benef Microbes; 2024 Aug; 15(6):539-563. PubMed ID: 39147373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
    John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
    J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer.
    Zou S; Yang C; Zhang J; Zhong D; Meng M; Zhang L; Chen H; Fang L
    J Transl Med; 2024 Feb; 22(1):175. PubMed ID: 38369542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer.
    Qu R; Zhang Y; Ma Y; Zhou X; Sun L; Jiang C; Zhang Z; Fu W
    Adv Sci (Weinh); 2023 Aug; 10(23):e2205563. PubMed ID: 37263983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers.
    Hale VL; Jeraldo P; Chen J; Mundy M; Yao J; Priya S; Keeney G; Lyke K; Ridlon J; White BA; French AJ; Thibodeau SN; Diener C; Resendis-Antonio O; Gransee J; Dutta T; Petterson XM; Sung J; Blekhman R; Boardman L; Larson D; Nelson H; Chia N
    Genome Med; 2018 Oct; 10(1):78. PubMed ID: 30376889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer.
    Zhang SL; Cheng LS; Zhang ZY; Sun HT; Li JJ
    Pharmacol Res; 2023 Feb; 188():106633. PubMed ID: 36574857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial markers in colorectal cancer detection and/or prognosis.
    Villéger R; Lopès A; Veziant J; Gagnière J; Barnich N; Billard E; Boucher D; Bonnet M
    World J Gastroenterol; 2018 Jun; 24(22):2327-2347. PubMed ID: 29904241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis.
    Conde-Pérez K; Aja-Macaya P; Buetas E; Trigo-Tasende N; Nasser-Ali M; Rumbo-Feal S; Nión P; Arribas EM; Estévez LS; Otero-Alén B; Noguera JF; Concha Á; Pardiñas-López S; Carda-Diéguez M; Gómez-Randulfe I; Martínez-Lago N; Ladra S; Aparicio LMA; Bou G; Mira Á; Vallejo JA; Poza M
    Mol Oncol; 2024 May; 18(5):1093-1122. PubMed ID: 38366793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyzing the Secretome of Gut Microbiota as the Next Strategy For Early Detection of Colorectal Cancer.
    Megat Mohd Azlan PI; Chin SF; Low TY; Neoh HM; Jamal R
    Proteomics; 2019 May; 19(10):e1800176. PubMed ID: 30557447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated study of metabolomics and gut metabolic activity from ulcerative colitis to colorectal cancer: The combined action of disordered gut microbiota and linoleic acid metabolic pathway might fuel cancer.
    Tang Q; Cang S; Jiao J; Rong W; Xu H; Bi K; Li Q; Liu R
    J Chromatogr A; 2020 Oct; 1629():461503. PubMed ID: 32858455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.